Orasure Technologies (OSUR) Cash & Equivalents (2010 - 2025)
Orasure Technologies (OSUR) posted Cash & Equivalents of $199.3 million for Q4 2025, down 7.95% sequentially from $216.5 million in Q3 2025, and down 25.58% YoY from $267.8 million in Q4 2024.
Orasure Technologies (OSUR) Cash & Equivalents (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Cash & Equivalents for 16 years, with the latest figure at $199.3 million in Q4 2025.
- Quarterly Cash & Equivalents fell 25.58% year-over-year to $199.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $199.3 million (down 25.58% YoY) and the FY2025 annual result came in at $199.3 million, down 25.58% from the prior year.
- Cash & Equivalents retreated to $199.3 million in Q4 2025 per OSUR's latest filing, from $216.5 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $290.4 million in Q4 2023 and troughed at $66.2 million in Q2 2022.
- A 5-year average of $180.9 million and a median of $192.6 million in 2023 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents sank 60.2% in 2022, then surged 245.8% in 2023.
- Over 5 years, Cash & Equivalents stood at $116.8 million in 2021, then dropped by 28.08% to $84.0 million in 2022, then soared by 245.8% to $290.4 million in 2023, then dropped by 7.8% to $267.8 million in 2024, then decreased by 25.58% to $199.3 million in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $199.3 million, $216.5 million, and $234.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - | 199.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 199.28 Mn |
| Sep 30, 2025 | 216.48 Mn |
| Jun 30, 2025 | 234.58 Mn |
| Mar 31, 2025 | 247.57 Mn |
| Dec 31, 2024 | 267.76 Mn |
| Sep 30, 2024 | 278.57 Mn |
| Jun 30, 2024 | 258.24 Mn |
| Mar 31, 2024 | 247.15 Mn |
| Dec 31, 2023 | 290.41 Mn |
| Sep 30, 2023 | 217.53 Mn |
| Jun 30, 2023 | 185.94 Mn |
| Mar 31, 2023 | 90.19 Mn |
| Dec 31, 2022 | 83.98 Mn |
| Sep 30, 2022 | 75.21 Mn |
| Jun 30, 2022 | 66.16 Mn |
| Mar 31, 2022 | 70.72 Mn |
| Dec 31, 2021 | 116.76 Mn |
| Sep 30, 2021 | 134.96 Mn |
| Jun 30, 2021 | 158.12 Mn |
| Mar 31, 2021 | 177.68 Mn |